<DOC>
	<DOCNO>NCT02101489</DOCNO>
	<brief_summary>This purpose study study see intra-operative urethral length measurement Foley catheter improve placement synthetic sling mid-urethra .</brief_summary>
	<brief_title>Precise Transvaginal Tape Placement Trial</brief_title>
	<detailed_description>This study assess effect intraoperative measurement urethral length Foley catheter optimization sling placement mid female urethra . Of note , Foley catheter well-tolerated , place routinely surgery drain bladder complication associate . Women choose undergo trans-vaginal tape sling ( TVT ) stress urinary incontinence ask enroll randomize trial study team clinic visit . Randomization perform FPMRS study nurse coordinator woman give informed consent meet study criterion . Twenty woman randomize undergo measurement urethral length mark Foley catheter urethral meatus place start surgical case . When catheter remove , length end Foley balloon mark urethra measure urethral length , mid urethral point determine divide urethral length two incision sling placement make twenty woman usual pre-operative assessment ( include intraoperative measurement urethral length Foley catheter ) treatment symptomatic stress urinary incontinence All woman participate study receive intra-operative 3-D trans-vaginal ultrasound ( BK Flex Focus ultrasound 8838 transvaginal probe ) . The image store review ; urethral length , urethral sphincter complex length width . All woman study ultrasound end surgical procedure follow-up ultrasound 2 week post operatively assess sling migration . Of note , transvaginal ultrasound well-tolerated complication associate . All ultrasound measurement do four qualified surgeon , Dr. Elizabeth Mueller Dr. Ahmed Akl , Dr. Tanaka Dune , Dr. Susanne Taege train ultrasound measurement . In addition , woman complete questionnaire assess pelvic floor symptom pre-operatively 2 week follow surgery . Instruments use Pelvic Floor Disorders Inventory ( PFDI ) , Medical Epidemiologic Social Aging ( MESA ) Patient Global Impression Improvement ( PGII ) [ 11 , 12 ] .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>Candidates TVT &gt; =18 year age participate Inability give inform consent Previous SUI ( stress urinary incontinence ) treatment include TVT , Burch urethral bulking agent Previous bladder , urethral malignancy vaginal/pelvic radiation treatment . Pregnant woman participate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>TVT</keyword>
	<keyword>Stress urinary incontinence</keyword>
</DOC>